INFLAMMATORY LUNG DISEASE

Clinical trials for INFLAMMATORY LUNG DISEASE explained in plain language.

Never miss a new study

Get alerted when new INFLAMMATORY LUNG DISEASE trials appear

Sign up with your email to follow new studies for INFLAMMATORY LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for controlling debilitating inflammation in rare immune disease

Disease control ENROLLING_BY_INVITATION

This early-stage study is testing whether the drug tofacitinib is safe and can help control severe inflammation in adults with chronic granulomatous disease (CGD). CGD is a rare immune disorder where people get frequent infections and often develop painful inflammation in their g…

Matched conditions: INFLAMMATORY LUNG DISEASE

Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

INFLAMMATORY LUNG DISEASE

Get alerted when new INFLAMMATORY LUNG DISEASE trials appear

New hope for controlling debilitating inflammation in rare immune disease